Literature DB >> 29803752

Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.

Mutsumi Nishida1, Kaoru Kahata2, Eiko Hayase3, Akio Shigematsu2, Megumi Sato4, Yusuke Kudo5, Satomi Omotehara5, Takahito Iwai5, Junichi Sugita2, Hitoshi Shibuya6, Chikara Shimizu7, Takanori Teshima3.   

Abstract

Sinusoidal obstruction syndrome (SOS)/hepatic veno-occlusive disease (VOD) is a well-documented complication after hematopoietic stem cell transplantation (HSCT). Transabdominal ultrasonography (US) enables the visualization of blood flow abnormalities and is therefore useful for the diagnosis of SOS/VOD. We herein prospectively evaluated accuracy of a novel US diagnostic scoring system of SOS/VOD based on US findings. We carried out US in 106 patients on day 14 and when SOS/VOD was suspected after allogeneic HSCT. Among 106 patients, 10 patients (9.4%) were diagnosed as SOS/VOD by Baltimore or Seattle criteria. According to univariate analysis of 17 US findings (US-17 screening), we established a novel scoring system (HokUS-10) consisting of 10 parameters, such as gallbladder wall thickening, ascites, and blood flow signal in the paraumbilical vein. The sensitivity and specificity were 100% and 95.8%, respectively. Diagnostic performance of the HokUS-10 was significantly better than US-17 screening. In 4 of 10 patients US detection of SOS/VOD preceded to clinical diagnosis. The HokUS-10 scoring system is useful in the diagnosis of SOS/VOD; however, our results should be validated in other cohorts.
Copyright © 2018 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Color Doppler; Hematopoietic stem cell transplantation; Hepatic veno-occlusive disease; Sinusoidal obstruction syndrome; Ultrasonography

Mesh:

Year:  2018        PMID: 29803752     DOI: 10.1016/j.bbmt.2018.05.025

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  9 in total

Review 1.  Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation.

Authors:  Mitchell S Cairo; Kenneth R Cooke; Hillard M Lazarus; Nelson Chao
Journal:  Br J Haematol       Date:  2020-03-04       Impact factor: 6.998

2.  Successful diagnosis of veno-occlusive disease caused by inotuzumab ozogamicin through minimal-invasive angiography: a case report.

Authors:  Michiaki Sato; Megumi Yasunaga; Masami Ohzu; Kazuhiro Toyama; Kumi Nakazaki; Fumio Nakahara; Takatoshi Kubo; Naoki Okura; Osamu Abe; Mineo Kurokawa
Journal:  Ann Hematol       Date:  2021-12-02       Impact factor: 3.673

3.  Usefulness of ultrasonography and elastography in diagnosing oxaliplatin-induced sinusoidal obstruction syndrome.

Authors:  Rika Saito; Yasuyuki Kawamoto; Mutsumi Nishida; Takahito Iwai; Yasuka Kikuchi; Isao Yokota; Ryo Takagi; Takahiro Yamamura; Ken Ito; Kazuaki Harada; Satoshi Yuki; Yoshito Komatsu; Naoya Sakamoto
Journal:  Int J Clin Oncol       Date:  2022-08-30       Impact factor: 3.850

Review 4.  Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Francesca Bonifazi; Francesco Barbato; Federico Ravaioli; Mariarosaria Sessa; Irene Defrancesco; Mario Arpinati; Michele Cavo; Antonio Colecchia
Journal:  Front Immunol       Date:  2020-04-03       Impact factor: 7.561

5.  Total body irradiation-based haploidentical hematopoietic stem cell transplantation using posttransplant cyclophosphamide after administration of inotuzumab ozogamicin: A case report.

Authors:  Masaya Abe; Nobuharu Fujii; Kentaro Mizuhara; Tomohiro Urata; Yuichi Sumii; Yuki Fujiwara; Keisuke Seike; Yasuhisa Sando; Makoto Nakamura; Keiko Fujii; Kyosuke Saeki; Yusuke Meguri; Noboru Asada; Daisuke Ennishi; Hisakazu Nishimori; Ken-Ichi Matsuoka; Yoshinobu Maeda
Journal:  Leuk Res Rep       Date:  2021-04-22

6.  Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia.

Authors:  Federico Ravaioli; Giovanni Marconi; Giovanni Martinelli; Elton Dajti; Chiara Sartor; Maria Chiara Abbenante; Luigina Vanessa Alemanni; Jacopo Nanni; Benedetta Rossini; Sarah Parisi; Luigi Colecchia; Gianluca Cristiano; Giovanni Marasco; Amanda Vestito; Stefania Paolini; Francesca Bonifazi; Antonio Curti; Davide Festi; Michele Cavo; Antonio Colecchia; Cristina Papayannidis
Journal:  Cancer Med       Date:  2021-12-30       Impact factor: 4.452

7.  [Chinese expert consensus on the diagnosis and management of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (2022)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-03-14

Review 8.  Early diagnostic value of liver stiffness measurement in hepatic sinusoidal obstruction syndrome induced by hematopoietic stem cell transplantation.

Authors:  You-Wen Tan; Yi-Chun Shi
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

9.  Imaging features of hepatic sinusoidal obstruction syndrome or veno-occlusive disease in children.

Authors:  Anneloes E Bohte; Miranda P Dierselhuis; Max M van Noesel; Maarten H Lequin
Journal:  Pediatr Radiol       Date:  2021-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.